Expert Review of the Evidence Base for Self-Therapy of Travelers' Diarrhea

被引：49

作者：

DuPont, Herbert L. ^{[1
,2
,3
,4
]}

Ericsson, Charles D. ^{[2
]}

Farthing, Michael J. G. ^{[5
,6
]}

Gorbach, Sherwood ^{[7
,8
,9
]}

Pickering, Larry K. ^{[10
]}

Rombo, Lars ^{[11
]}

Steffen, Robert ^{[12
]}

Weinke, Thomas ^{[13
]}

机构：

[1] Univ Texas Sch Publ Hlth Houston, Ctr Infect Dis, Houston, TX 77030 USA

[2] Univ Texas Sch Med Houston, Div Infect Dis, Dept Internal Med, Houston, TX USA

[3] St Lukes Episcopal Hosp, Internal Med Serv, Houston, TX 77030 USA

[4] Baylor Coll Med, Dept Med, Houston, TX 77030 USA

[5] Univ Brighton, Brighton, E Sussex, England

[6] Sussex Med Sch, Brighton, E Sussex, England

[7] Tufts Univ, Sch Med, Dept Publ Hlth, Boston, MA 02111 USA

[8] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA

[9] Tufts Univ, Sch Med, Dept Microbiol, Boston, MA 02111 USA

[10] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA

[11] Karolinska Inst, Malaria Res Lab, Stockholm, Sweden

[12] Univ Zurich, Zurich, Switzerland

[13] Klinikum Ernst von Bergmann Clin, Med Clin, Potsdam, Germany

来源：

JOURNAL OF TRAVEL MEDICINE | 2009年 / 16卷 / 03期

关键词：

DIFFICILE-ASSOCIATED-DIARRHEA; HEMOLYTIC-UREMIC SYNDROME; ORAL REHYDRATION THERAPY; IRRITABLE-BOWEL-SYNDROME; JEJUNI SUBSP-JEJUNI; DOUBLE-BLIND TRIAL; IN-VITRO ACTIVITY; CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; TRIMETHOPRIM-SULFAMETHOXAZOLE;

D O I：

10.1111/j.1708-8305.2009.00300.x

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

[No abstract available]

引用

页码：161 / 171

页数：11

共 112 条

[1] Azithromycin found to be comparable to levofloxacin for the treatment of US travelers with acute diarrhea acquired in Mexico [J].

Adachi, JA ;

Ericsson, CD ;

Jiang, ZD ;

DuPont, MW ;

Martinez-Sandoval, F ;

Knirsch, C ;

DuPont, HL .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (09) :1165-1171

[2] Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world [J].

Adachi, JA ;

Jiang, ZD ;

Mathewson, JJ ;

Verenkar, MP ;

Thompson, S ;

Martinez-Sandoval, F ;

Steffen, R ;

Ericsson, CD ;

DuPont, HL .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (12) :1706-1709

[3]

AHMAD SR, 1992, PEDIATRICS, V89, P980

[4]

Ambrose Paul G, 2005, Treat Respir Med, V4 Suppl 1, P5

[5] THERAPY FOR SHIGELLOSIS .2. RANDOMIZED, DOUBLE-BLIND COMPARISON OF CIPROFLOXACIN AND AMPICILLIN [J].

BENNISH, ML ;

SALAM, MA ;

HAIDER, R ;

BARZA, M .

JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (03) :711-716

[6] Low risk of hemolytic uremic syndrome after early effective antimicrobial therapy for Shigella dysenteriae type 1 infection in Bangladesh [J].

Bennish, ML ;

Khan, WA ;

Begum, M ;

Bridges, EA ;

Ahmed, S ;

Saha, D ;

Salam, MA ;

Acheson, D ;

Ryan, ET .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (03) :356-362

[7] TREATMENT OF SHIGELLOSIS .3. COMPARISON OF ONE-DOSE OR 2-DOSE CIPROFLOXACIN WITH STANDARD 5-DAY THERAPY - A RANDOMIZED, BLINDED TRIAL [J].

BENNISH, ML ;

SALAM, MA ;

KHAN, WA ;

KHAN, AM .

ANNALS OF INTERNAL MEDICINE, 1992, 117 (09) :727-734

[8] ANTIMICROBIAL RESISTANCE OF SHIGELLA ISOLATES IN BANGLADESH, 1983-1990 - INCREASING FREQUENCY OF STRAINS MULTIPLY RESISTANT TO AMPICILLIN, TRIMETHOPRIM-SULFAMETHOXAZOLE, AND NALIDIXIC-ACID [J].

BENNISH, ML ;

SALAM, MA ;

HOSSAIN, MA ;

MYAUX, J ;

KHAN, EH ;

CHAKRABORTY, J ;

HENRY, F ;

RONSMANS, C .

CLINICAL INFECTIOUS DISEASES, 1992, 14 (05) :1055-1060

[9]

BLACK RE, 1990, REV INFECT DIS, V12, pS73

[10]

BROWN KH, 1994, PEDIATRICS, V93, P17

← 1 2 3 4 5 6 7 8 9 10 →